These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7185724)

  • 1. The importance of patent term restoration to pharmaceutical innovation.
    Hutt PB
    Health Aff (Millwood); 1982; 1(2):6-24. PubMed ID: 7185724
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of patent term restoration to small, high technology companies.
    Kiley TD
    Health Aff (Millwood); 1982; 1(2):46-52. PubMed ID: 7185722
    [No Abstract]   [Full Text] [Related]  

  • 3. Patent term extension: an expensive and unnecessary giveaway.
    Gore A
    Health Aff (Millwood); 1982; 1(2):25-33. PubMed ID: 10621692
    [No Abstract]   [Full Text] [Related]  

  • 4. Patent watch: the patent cliff steepens.
    Harrison C
    Nat Rev Drug Discov; 2011 Jan; 10(1):12-3. PubMed ID: 21193859
    [No Abstract]   [Full Text] [Related]  

  • 5. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
    Higgins MJ; Graham SJ
    Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944
    [No Abstract]   [Full Text] [Related]  

  • 6. Realizing two-tiered innovation policy through drug regulation.
    Ridgway WE
    Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807
    [No Abstract]   [Full Text] [Related]  

  • 7. Maintaining patents protecting biologics or small-molecule drugs.
    Marimuthu G; Kumari S; Kandasamy M; Raghunathan S; Saberwal G
    Nat Biotechnol; 2012 Jan; 30(1):50-3. PubMed ID: 22231094
    [No Abstract]   [Full Text] [Related]  

  • 8. Patent watch.
    Harrison C
    Nat Rev Drug Discov; 2013 Jan; 12(1):14-5. PubMed ID: 23274462
    [No Abstract]   [Full Text] [Related]  

  • 9. A day late and a few million dollars short.
    Goldenson D
    Nat Biotechnol; 2009 Jun; 27(6):538-41. PubMed ID: 19513055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patents: a threat to innovation?
    Manocaran M
    Science; 2010 Jan; 327(5961):31-2; author reply 32. PubMed ID: 20044557
    [No Abstract]   [Full Text] [Related]  

  • 11. Patent lifecycle management strategies in open innovation projects.
    Lee Y; Fong EA
    Drug Discov Today; 2020 Oct; 25(10):1782-1785. PubMed ID: 32592662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sending pharma better signals.
    Avorn J
    Science; 2005 Jul; 309(5735):669. PubMed ID: 16051753
    [No Abstract]   [Full Text] [Related]  

  • 13. The Myth of the Free Market for Pharmaceuticals.
    Conti RM; Frank RG; Cutler DM
    N Engl J Med; 2024 Apr; 390(16):1448-1450. PubMed ID: 38647106
    [No Abstract]   [Full Text] [Related]  

  • 14. Patent reform in the US: what's at stake for pharmaceutical innovation?
    Yancey A; Stewart CN
    Expert Opin Ther Pat; 2010 May; 20(5):603-8. PubMed ID: 20402544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging effects of the Drug Price Competition and Patent Term Restoration Act of 1984.
    Lewis RA
    J Contemp Health Law Policy; 1992; 8():361-78. PubMed ID: 10118987
    [No Abstract]   [Full Text] [Related]  

  • 16. The importance of patent term restoration to pharmaceutical innovation.
    Huntt PB
    Health Aff (Millwood); 1982; 1(2):6-24. PubMed ID: 10324213
    [No Abstract]   [Full Text] [Related]  

  • 17. Face-off will new drugs pay off in time to counter patent losses for Forest Laboratories?
    Vukhac K; Rivkind I
    Fortune; 2012 Jun; 165(8):80. PubMed ID: 22741415
    [No Abstract]   [Full Text] [Related]  

  • 18. Patent laws: could changes enhance drug development?
    Mattes JA
    Arch Gen Psychiatry; 1997 Oct; 54(10):970. PubMed ID: 9337779
    [No Abstract]   [Full Text] [Related]  

  • 19. It is not unethical, though it is often unwise, to override patents.
    Leventer H
    Am J Bioeth; 2002; 2(3):50-1. PubMed ID: 12230860
    [No Abstract]   [Full Text] [Related]  

  • 20. The Cipro patent and bioterrorism.
    Kaye KS; Kaye D
    Am J Bioeth; 2002; 2(3):41-2. PubMed ID: 12230854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.